Altimmune, Inc.

US$2.08As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ALTHealthcare
Country USA
PE (Fwd) •••
TSR 9Y CAGR (35.34%)
Div yield —
ROE (28.87%)
Biotechnology
Beta (5Y) 0.15
PE TTM —
TSR TTM (48.64%)
Mkt cap US$404.6M
ROIC (17.95%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.23
7.21%
(48.74%)
Hold 12|12|2|8|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
22.23%
21.29%
5.06%
(3.57%)
Revenue$M
20.80
20.80
21.83
21.29
13.83%
7.87%
8.10%
2.83%
Peers (US$404.6M)
Cap (US$)
PE
407.0M
—
Capital
TTM
5Y
10Y
Leveragex
0.423
0.420
0.397
EBIT/Intx
0.398
0.102
0.081
Own earn%
327.69
73.63
87.70
Sh yield%
23.68
17.28
17.26
Owners
Insiders/Inst%
0.15
33.95
Short interest%
3.23
SBC / revenue%
3.97
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
3–7
$1 testx
0.4
Incr. ROIC%
2